Cuts, shakeup at the federal level impact local non-profit UETHDA
KINGSPORT, Tenn. (WJHL) — Many local residents who need help with their energy costs often turn to the federally funded LIHEAP program for help.
Through the low-income home energy assistance program, families can receive a one-time payment of up to $1,000 to help offset the costs of electricity, gas or even firewood needed for energy.
The program is facilitated locally through the Upper East Tennessee Human Development Agency (UETHDA).
During the COVID-19 pandemic, more money was added to the program, but UETHDA Executive Director Tim Jaynes said Monday that Covid-era funding is ending.
Unable to get $2M in time, org. still hopes for air service expansion at Tri-Cities Airport
'Our program as a whole, we are seeing changes in the fact that the COVID money is drying up,' he said. 'So we are seeing a reduction there, and that's about a 20% reduction that we will see throughout the LIHEAP program.'
At the height of the funding, about 12,000 residents in eight Northeast Tennessee counties were served. Now, Jaynes said about a thousand fewer will receive those funds.
Those recipients will be determined by a points system that assesses the severity of need. So, even though a family may qualify, the funding may not be there to help. But Jaynes encourages residents to still reach out because help may come from another source.
'We are always there, so they can go to their neighborhood service centers or they can contact us at main office. We have a lot of other resources that are available. There's a lot of churches that are available with funding, and there's a lot of, just other organizations that step up and help.'
In addition to the COVID-19 funding cuts, nearly all of the staff who ran the LIHEAP program in Washington DC were laid off as part of the restructuring of the Department of Health and Human Services.
Jaynes says it's unclear how that decision will impact them locally yet, but hopes the administration will see the value in their programs and make no further cuts.
'Historically, we have seen good results from our programs. We've seen good outcomes. We've seen people moving forward, historically. Also, the administration has liked our programs; and Congress likes our programs. That's why they've continued to fund them. We do not foresee any major drastic cuts, but we're all in a wait-and-see. We don't know what tomorrow holds.'
Jaynes adds that UETHDA gives a helping hand, not a handout, and when a client receives assistance, financial counseling is also provided.
'One aspect to the LIHEAP program is when someone comes into our office and works with us, we also work with them on financial literacy. So while it is a small portion of their annual budgeting, we help them with other things and we try and wrap our arms around everyone that walks in the office, because our goal is to eradicate poverty and help them move forward.'
As far as local jobs impacted by these cuts, Jaynes didn't want to comment on that until they officially know more.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
‘Phasmophobia' Film in the Works: Blumhouse Developing Adaptation of Horror Video Game
Blumhouse Productions has set its sights on another horror video game to adapt to film, developing a feature based on 'Phasmophobia,' the first-person paranormal puzzle title that became a viral sensation during the COVID pandemic. The film adaptation will be produced by Blumhouse and Atomic Monster, in association with Kinetic Games Limited. No distributor or release date has been set. More from Variety 'M3GAN 2.0' Trailer: M3GAN Gets an Upgrade and Faces Another Killer Robot in Horror Sequel 'M3GAN 2.0' Teaser Has the Killer Doll Dancing to Chappell Roan's 'Femininomenon' and Proclaiming: 'The B-- Is Back' Box Office: 'Speak No Evil' Pipes in With $4.9 Million Opening Day, 'Beetlejuice 2' Still Shaking on Top First released in early access in 2020, 'Phasmophobia' became a social media fixation as Twitch streamers and YouTubers quickly took to the multiplayer ghost-hunting video game. Developed and released by Kinetic Games Limited, the title was a breakthrough hit for the indie banner, becoming the best-selling video game on Steam for several weeks through the final months of that year. It has been ported to several consoles and has sold more than 23 million copies globally in the time since. 'Phasmophobia' was also a critical darling, taking the prize in the category of best debut game at the 2020 Game Awards. The project was unveiled at the first-ever 'Business of Fear' event in Hollywood on Tuesday, which featured Blumhouse CEO Jason Blum and president Abhijay Prakash as speakers. It comes as Blumhouse's latest video game adaptation, following their 2023 title 'Five Nights at Freddy's' — another film based on a streamer-popularized horror game. That Universal release grossed $291 million worldwide — an especially impressive figure, considering it had a simultaneous streaming debut on Peacock in North America. A sequel, 'Five Nights at Freddy's 2,' will be released to theaters on Dec. 5. Blumhouse also sports a game division, with upcoming titles including 'Eyes of Hellfire' and 'Sleep Awake.' Best of Variety What's Coming to Netflix in June 2025 New Movies Out Now in Theaters: What to See This Week 'Harry Potter' TV Show Cast Guide: Who's Who in Hogwarts?
Yahoo
an hour ago
- Yahoo
Why BioNTech Stock Soared Today
BioNTech and Bristol Myers Squibb are teaming up to develop a new cancer drug, BNT327. BioNTech has moved the drug into phase 3 trials, and now Bristol will help to fund further trials. Cash payments to BioNTech could exceed $11 billion over time. 10 stocks we like better than BioNTech Se › BioNTech (NASDAQ: BNTX), one of the companies made famous for its role developing vaccines with Pfizer (NYSE: PFE) during the COVID-19 pandemic, soared 20.2% through 12:50 p.m. Monday on news entirely unrelated to COVID. The German biotech announced this morning it is partnering with pharmaceuticals giant Bristol Myers Squibb (NYSE: BMY) to "co-develop and co-commercialize" BioNTech's drug candidate BNT327 as an immunotherapy against multiple kinds of cancer. BioNTech and Bristol will evenly split the costs of developing and commercializing BNT327, and will "work jointly to broaden and accelerate the development of this clinical candidate." The drug is already involved in "multiple" ongoing clinical trials, including an advanced phase 3 trial testing its usefulness in treating breast cancer and both small cell and non-small cell lung cancer. BioNTech CEO Dr. Uğur Şahin expressed the belief that "BNT327 has the potential to become a foundational immuno-oncology backbone, moving beyond single-mechanism checkpoint inhibitors and expanding into multiple solid-tumor indications." Bristol CEO Christopher Boerner agreed that BNT327 has "significant potential for transforming the standard of care for patients with solid tumors." There are more immediate benefits for BioNTech stock, beginning with Bristol Myers Squibb paying BioNTech $1.5 billion up front for the rights to team up and a further $2 billion in noncontingent payments through 2028 as drug development continues. Additional developmental, regulatory, and commercial milestones, which are contingent on successful development, could add a further $7.6 billion to BioNTech's balance sheet over time. With its lucrative COVID days behind it, BioNTech reported nearly $690 million in losses last year and turned free-cash-flow negative. A tidal wave of cash from Bristol Myers Squibb could really come in handy right about now. Before you buy stock in BioNTech Se, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and BioNTech Se wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bristol Myers Squibb and Pfizer. The Motley Fool recommends BioNTech Se. The Motley Fool has a disclosure policy. Why BioNTech Stock Soared Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Carlisle-based MD named 'Car Finance Business Leader of the Year'
The managing director of Borderway Finance in Carlisle has received an industry award. Mike Deans has been named 'Car Finance Business Leader of the Year' at the Car Finance Awards at The Monastery in Manchester. Mr Deans said: "It was a shock when they read my name out. "It's one of the biggest events in the industry with some huge businesses in the room. "This isn't just for me, it's recognition for everyone at Borderway." Mr Deans was joined at the black-tie awards ceremony by Charlee Byers, sales support administrator, and Leah Farish, administration assistant. He joined Borderway Finance in 1998 as a trainee account manager and worked his way up to sales and marketing director before becoming managing director in 2016. He credited his team for the company's success. Mr Deans said: "The business is all about the people. "You have to have the right people. "If they're not receptive and don't want to come on the journey with you, you'll fail. "This is a great accolade for everyone at Borderway Finance." According to a spokesperson for the company, "Borderway's sales have grown strongly, especially since the Covid pandemic. "It provides exceptional customer service, achieving Feefo's top Platinum Service Award – based on verified customer reviews – for the last four years." Mr Deans' leadership has helped the company earn a three-star rating from Best Companies for 'world-class' workplace engagement. He has also chaired a car finance interest group for the Consumer Credit Trade Association and joined the association's board in November 2023. In addition, he was invited to join Credit 500, a network of leading figures in the credit industry, and has served since 2023 as a director of People First, an advocacy charity based in Carlisle. Mr Deans said: "Whatever you do in business, there's always a customer at the end of it who expects a level of service and expects to be looked after." Outside of work, Mr Deans enjoys photography, videography, and spending time with his family and their Staffordshire bull terrier, Cooper. If Mr Deans hadn't worked in car finance, he might have been a DJ – given he used to present the weekend breakfast show on CFM.